Back

Guideline-directed medical therapy across neighbourhood socioeconomic deprivation in patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry

9 May 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Socioeconomics and regional heterogeneity of heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Valeria Valente

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Regional heterogeneity in adult vaccination uptake among remotely monitored heart failure patients in France: a cross-sectional survey
Professor N. Girerd (Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Heart failure with preserved ejection fraction: who are our patients?
Doctor J. Fernandes (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Twenty years of ESC heart failure guidelines: evolution of recommendation strength and evidence quality
Doctor R. Santos (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
A comparison of the social determinants and self-care behaviours of women at risk and with heart failure between 4 socio-economic groups in Ireland: An interim report from the her-heartbeat project.
Ms M. Ryder (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Clinical, genetic, and prognostic implications of illicit drug use in dilated cardiomyopathy
Miss S. Stroeks (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Socioeconomics and regional heterogeneity of heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
Socioeconomic disparities in guideline directed medical therapy for HFrEF: a population-based cohort study using electronic health records (the Netherlands)
thumbnail
Congress Presentation
Health disparities in heart failure with reduced ejection fraction among immigrants in Sweden: data from the Swedish Heart Failure Registry
thumbnail
Congress Presentation
Improvements in medical therapy and prognosis for patients with HFrEF following the 2021 ESC HF Guidelines: a nationwide registry study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources